Hypertension Diagnostics Company Profile

02:33 EST 11th December 2018 | BioPortfolio

Hypertension Diagnostics, Inc., headquartered in Eagan, Minnesota, was founded in July 1988 to develop a proprietary blood pressure waveform analysis methodology into a non-invasive means for measuring the elasticity of large and small arteries. HDI has developed proprietary blood pressure waveform analysis technology which has been incorporated into the design of several products


2915 Waters Road, Suite 108
United States of America


Phone: 651-687-9999
Fax: 651-687-0485

News Articles [781 Associated News Articles listed on BioPortfolio]

Under Pressure! – How Music Can Help Control Hypertension

The Background An estimated 1 billion people are affected by

Hypertension in Pregnancy: A CVD Red Flag Not to Be Ignored

Transient gestational hypertension and pre-eclampsia are warning signs for increased and earlier risk for chronic hypertension, type 2 diabetes, and hypercholesterolemia, say researchers. Medscape M...

Hypertension Overview Video

This video explains the diagnostic cutoffs for the various stages in hypertension, as well as the pathophysiology and some common causes of hypertension. Osmosis

Hypertension Among Youths -- United States, 2001-2016

New guidelines released by the American Academy of Pediatrics for determining hypertension in children have resulted in a marked increase of U.S. youths being reclassified as having hypertension. Mo...

PDE3A gene screening improves diagnostics for patients with Bilginturan syndrome (hypertension and brachydactyly syndrome)

Application of a Tool to Identify Undiagnosed Hypertension

A new CDC-developed tool, the Million Hearts Hypertension Prevalence Estimator Tool, helps organizations predict their patient population's hypertension prevalence. Morbidity & Mortality Weekly Repo...

Treatment of hypertension in low-risk patients not linked with improved outcomes

1. In this retrospective cohort study of low-risk patients with mild hypertension, treatment of hypertension was not linked to any change in mortality or cardiovascular disease. 2. In this low-risk po...

AHA: Resistant Hypertension Diagnosis, Tx Guidelines Updated

THURSDAY, Sept. 13, 2018 -- A correct diagnosis of resistant hypertension is necessary to avoid overmedicating, according to a scientific statement from the American Heart Association published online...

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1342 Associated PubMed Articles listed on BioPortfolio]

Enhancing Mitochondrial Health to Treat Hypertension.

This review summarizes literature pertaining to the dawning field of therapeutic targeting of mitochondria in hypertension and discusses the potential of these interventions to ameliorate hypertension...

Sociodemographics and hypertension control among young adults with incident hypertension: a multidisciplinary group practice observational study.

Despite a growing prevalence of hypertension, young adults (18-39-year-olds) have lower hypertension control rates compared with older adults. The purpose of this study was to evaluate the role of soc...

Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension: Erratum.

Secondary hypertension in patients with saccular intracranial aneurysm disease: A population based study.

Secondary hypertension is a serious form of hypertension, involving 5% to 10% of all hypertension patients. Hypertension is a risk factor of the saccular intracranial aneurysm (sIA) disease and subara...

Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension.

Heterogeneous causes can determinate hypertension.

Clinical Trials [2823 Associated Clinical Trials listed on BioPortfolio]

Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography

The aim of the study is to determine relevant hemodynamic parameters for the diagnostics of pulmonary arterial hypertension (PAH) by dynamic contrast enhanced dual-energy CT (DE-CT). In th...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

Companies [1022 Associated Companies listed on BioPortfolio]

Hypertension Diagnostics

Hypertension Diagnostics, Inc., headquartered in Eagan, Minnesota, was founded in July 1988 to develop a proprietary blood pressure waveform analysis methodology into a non-invasive means for measurin...

Pulmonary Hypertension Association (PHA)

Headquartered in Silver Spring, Md., PHA is the country’s leading organization connecting pulmonary hypertension patients, families, and medical professionals. Its mission is...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Tenax Therapeutics, Inc. 

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The Company has a wor...

Pulmonary Hypertension Association

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual. The...

More Information about "Hypertension Diagnostics" on BioPortfolio

We have published hundreds of Hypertension Diagnostics news stories on BioPortfolio along with dozens of Hypertension Diagnostics Clinical Trials and PubMed Articles about Hypertension Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hypertension Diagnostics Companies in our database. You can also find out about relevant Hypertension Diagnostics Drugs and Medications on this site too.

Quick Search


Relevant Topic

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record